InsidersTradesSigma
Total declarations
Companies
▲ Purchases (2 ops.)
▼ Sales (5 ops.)
Insider track record
CFODisclosed buys
2
Disclosed sells
5
T+90 hit rate
0%
T+90 mean return
-46.6%
Across 2 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Discover the full record of transactions filed by Sullivan Lynne Marie, Chief Financial Officer. Insider active across 2 companies, notably Unity Biotechnology, Inc.. Cumulatively, 12 filings have been logged. Split: 2 buys · 5 sells. Total volume traded: €106k. History available since 24 June 2021. The latest transaction was disclosed on 2 April 2025 (Cession). Regulator: SEC (Form 4). All data is accessible without signup.
Declarations12 total
21,867 shares@ US$1.0374.0% of flowCommon Stock, $0.0001 par valueSEC:0000950170-25-050410:0
65,000 shares0Common Stock, $0.0001 par valueSEC:0000950170-25-047746:0
153 shares@ US$2.231.2% of flowCommon Stock, $0.0001 par valueSEC:0000950170-25-014570:0
136 shares@ US$1.290.6% of flowCommon Stock, $0.0001 par valueSEC:0000950170-24-122295:0
139 shares@ US$1.530.7% of flowCommon Stock, $0.0001 par valueSEC:0000950170-24-091964:0
324 shares@ US$1.401.5% of flowCommon Stock, $0.0001 par valueSEC:0000950170-24-077848:0
925 shares@ US$6.8922.0% of flowCommon Stock, $0.0001 par valueSEC:0000899243-22-036537:0
50,000 shares0Common Stock, $0.0001 par valueSEC:0000899243-22-006446:0
12,500 shares@ US$4.000.32% mcap50.0% of flowCommon StockSEC:0001213900-21-039439:0
Ideal exit: 24 Apr 2022 (T+270)
12,500 shares@ US$4.0050.0% of flowCommon StockSEC:0001213900-21-039439
Ideal exit: 24 Apr 2022 (T+270)
30,833 shares0Common Stock, $0.0001 par valueSEC:0000899243-21-026230:0
30,833 shares0Common Stock, $0.0001 par valueSEC:0000899243-21-026230
12 of 12 declarations
About Sullivan Lynne Marie
Lynne Marie Sullivan is the Chief Financial Officer and Head of Corporate Development at Unity Biotechnology, Inc. and BiomX Inc. She oversees financial management and strategic development initiatives. Her expertise is essential for the growth of both companies.
